1 paper
Adquate Mhlanga, Louis Shekhtman, Ashish Goyal +11
The entry inhibitor Bulevirtide (BLV) was recently approved in Europe for treatment of chronic hepatitis D virus (HDV) infection, which is considered the most severe viral hepatiti…